Table of Contents
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List Of Secondary Sources
1.8 Objectives
1.8.1 Objective 1:
1.8.2 Objective 2:
1.8.3 Market Estimation For Flow Cytometry Market
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Flow Cytometry Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.2.1 Key Opportunities Prioritized, By Product
3.2.2 Key Opportunities Prioritized, By Technology
3.2.3 Key Opportunities Prioritized, By Application
3.2.4 Key Opportunities Prioritized, By End Use
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Growing Prevalence Of Chronic And Infectious Diseases
3.3.1.2 High R&D Investments In Biotechnology, Clinical, And Life Science Research
3.3.1.3 Technological Advancements In Flow Cytometry Instruments And Reagents
3.3.1.4 Increasing Demand For Point-Of-Care Diagnostics
3.3.2 Market Restraint Analysis
3.3.2.1 High Cost Of Instruments
3.3.3 Market Challenges
3.3.3.1 Low Cell Throughput Rate
3.4 Flow Cytometry: Market Analysis Tools
3.4.1 Industry Analysis – Porter’s
3.4.2 Flow Cytometry – Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.5 Regulatory & Reimbursement Scenario
3.6 Pricing Analysis
3.7 Trade Data
3.7.1 Import/Export Data For Flow Cytometers, By Country
3.8 Covid-19 Impact Analysis
Chapter 4 Product Business Analysis
4.1 Flow Cytometry Market: Product Movement Analysis, 2021 & 2030
4.2 Instruments
4.2.1 Global Instruments Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.2.2 Cell Analyzers
4.2.2.1 Global Cell Analyzers Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.2.3 Cell Sorters
4.2.3.1 Global Cell Sorters Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.3 Reagents & Consumables
4.3.1 Global Reagents & Consumables Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.4 Software
4.4.1 Global Software Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.5 Accessories
4.5.1 Global Accessories Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.6 Services
4.6.1 Global Services Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 5 Technology Business Analysis
5.1 Flow Cytometry Market: Technology Movement Analysis, 2021 & 2030
5.2 Cell-Based
5.2.1 Global Cell-Based Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.3 Bead-Based
5.3.1 Global Bead-Based Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 6 Application Business Analysis
6.1 Flow Cytometry Market: Application Movement Analysis, 2021 & 2030
6.2 Research
6.2.1 Global Research Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.2 Pharmaceutical
6.2.2.1 Global Pharmaceutical Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.2.2 Drug Discovery
6.2.2.2.1 Global Drug Discovery Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.2.3 In Vitro Toxicity
6.2.2.3.1 Global In Vitro Toxicity Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.2.4 Stem Cell
6.2.2.4.1 Global Stem Cell Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.3 Apoptosis
6.2.3.1 Global Apoptosis Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.4 Cell Sorting
6.2.4.1 Global Cell Sorting Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.5 Cell Cycle Analysis
6.2.5.1 Global Cell Cycle Analysis Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.6 Immunology
6.2.6.1 Global Immunology Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.7 Cell Viability
6.2.7.1 Global Cell Viability Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3 Industrial
6.3.1 Global Industrial Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4 Clinical
6.4.1 Global Clinical Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4.2 Cancer
6.4.2.1 Global Cancer Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4.3 Organ Transplantation
6.4.3.1 Global Organ Transplantation Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4.4 Immunodeficiency
6.4.4.1 Global Immunodeficiency Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4.5 Hematology
6.4.5.1 Global Hematology Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 7 End Use Business Analysis
7.1 Flow Cytometry Market: End-Use Movement Analysis, 2021 & 2030
7.2 Commercial Organizations
7.2.1 Global Commercial Organizations Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.2.2 Biotechnology Companies
7.2.2.1 Global Biotechnology Companies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.2.3 Pharmaceutical Companies
7.2.3.1 Global Pharmaceutical Companies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.2.4 CROS
7.2.4.1 Global CROS Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.3 Hospitals
7.3.1 Global Hospitals Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.4 Academic Institutes
7.4.1 Global Academic Institutes Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.5 Clinical Testing Labs
7.5.1 Global Clinical Testing Labs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 8 Regional Business Analysis
8.1 Flow Cytometry Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.3 Europe
8.3.1 Europe Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.3.2 Germany
8.3.2.1 Germany Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.3.4 France
8.3.4.1 France Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Italy Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Spain Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.3.7 Russia
8.3.7.1 Russia Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.4.3 China
8.4.3.1 China Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.4.4 India
8.4.4.1 India Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.4.5 South Korea
8.4.5.1 South Korea Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.4.6 Australia
8.4.6.1 Australia Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.4.7 Singapore
8.4.7.1 Singapore Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.6 Middle East & Africa
8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.6.4 UAE
8.6.4.1 UAE Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 9 Flow Cytometry Market Competitive Landscape
9.1 Recent Developments & Impact Analysis, By Key Market Participants
9.2 Company Categorization
9.3 Vendor Landscape
9.3.1 List Of Key Distributors And Channel Partners
9.4 Public Companies
9.4.1 Company Market Position Analysis
9.4.2 Global Key Company Market Share Analysis, 2021
9.5 Private Companies
9.5.1 List Of Key Emerging Companies
9.5.2 Company Market Position Analysis
9.6 Regional Network Map
9.7 Company Profiles
9.7.1 DANAHER CORPORATION
9.7.1.1 Company overview
9.7.1.2 Beckman Coulter, Inc.
9.7.1.2.1 COMPANY OVERVIEW
9.7.1.3 Cytiva
9.7.1.3.1 COMPANY OVERVIEW
9.7.1.4 Financial performance
9.7.1.5 Product benchmarking
9.7.1.6 Strategic initiatives
9.7.2 BECTON, DICKINSON AND COMPANY (BD)
9.7.2.1 Company overview
9.7.2.2 Financial performance
9.7.2.3 Product benchmarking
9.7.2.4 Strategic initiatives
9.7.3 SYSMEX CORPORATION
9.7.3.1 Company overview
9.7.3.2 Financial performance
9.7.3.3 Product benchmarking
9.7.3.4 Strategic initiatives
9.7.4 AGILENT TECHNOLOGIES, INC.
9.7.4.1 Company overview
9.7.4.2 Financial performance
9.7.4.3 Product benchmarking
9.7.4.4 Strategic initiatives
9.7.5 APOGEE FLOW SYSTEMS LTD.
9.7.5.1 Company overview
9.7.5.2 Product benchmarking
9.7.5.3 Strategic initiatives
9.7.6 BIO-RAD LABORATORIES, INC.
9.7.6.1 Company overview
9.7.6.2 Financial performance
9.7.6.3 Product benchmarking
9.7.6.4 Strategic initiatives
9.7.7 THERMO FISHER SCIENTIFIC, INC.
9.7.7.1 Company overview
9.7.7.2 Financial performance
9.7.7.3 Product benchmarking
9.7.7.4 Strategic initiatives
9.7.8 STRATEDIGM, INC.
9.7.8.1 Company overview
9.7.8.2 Product benchmarking
9.7.8.3 Strategic initiatives
9.7.9 DIASORIN S.P.A.
9.7.9.1 Company overview
9.7.9.2 Luminex Corporation
9.7.9.2.1 COMPANY OVERVIEW
9.7.9.3 Financial performance
9.7.9.4 Product benchmarking
9.7.9.5 Strategic initiatives
9.7.10 MILTENYI BIOTEC
9.7.10.1 Company overview
9.7.10.2 Product benchmarking
9.7.10.3 Strategic initiatives
9.7.11 SONY BIOTECHNOLOGY, INC.
9.7.11.1 Company overview
9.7.11.2 Product benchmarking
9.7.11.3 Strategic initiatives